L-Dex U 400 for lymphoedema after breast cancer treatment


    The main points from the evidence summarised in this briefing are from 3 studies in the UK and the US using prospective observational data, as well as a budget impact analysis, in a total of 978 patients (female adults) in secondary care. They show that the L-Dex U400 is less effective than comparators in diagnosing lymphoedema, but potentially helps detect… (More)


    • Presentations referencing similar topics